Neumentum

About:

Neumentum is a neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products.

Website: http://neumentum.com/

Top Investors: AngelMD, Evolution VC Partners

Description:

Neumentum neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products. At Neumentum, we are dedicated to developing safe, effective treatment options that address unmet needs in the management of pain, without the potential risks of misuse, addiction, or life-threatening side effects that may be found with opioid products. Neumentum has global rights to five novel non-opioid pain products, the most advanced of which are two phase 3-ready injectable products under development for acute postsurgical pain.

Total Funding Amount:

$34.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Morristown, New Jersey, United States

Founded Date:

2017-03-28

Contact Email:

info(AT)neumentum.com

Founders:

Joseph Pergolizzi, R. Scott Shively

Number of Employees:

1-10

Last Funding Date:

2021-10-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai